Compare · STEM vs TMO
STEM vs TMO
Side-by-side comparison of Stem Inc. (STEM) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- STEM operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $179.15B, about 1996.1x STEM ($89.7M).
- Over the past year, STEM is down 7.8% and TMO is up 18.4% - TMO leads by 26.2 points.
- TMO has been more active in the news (19 items in the past 4 weeks vs 5 for STEM).
- Both have 25 recent analyst ratings on file.
- Company
- Stem Inc.
- Thermo Fisher Scientific Inc
- Price
- $9.08-9.47%
- $473.94-1.69%
- Market cap
- $89.7M
- $179.15B
- 1M return
- -10.67%
- +2.47%
- 1Y return
- -7.78%
- +18.44%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 1992
- News (4w)
- 5
- 19
- Recent ratings
- 25
- 25
Stem Inc.
Stem, Inc. provides artificial intelligence (AI)-driven clean energy storage services. It delivers and operates smart battery storage solutions that maximize renewable energy generation and help build a resilient grid. The company's Athena, a AI-powered analytics platform software that uses artificial intelligence and machine learning to automatically switch between battery power, onsite generation, and grid power. Athena stabilizes the grid, reduces carbon emissions, and solves renewable intermittency across the network of distributed energy storage systems. The company serves customers, including Fortune 500 corporate energy users, project developers and installers, and utilities and independent power producers. Stem, Inc. was founded in 2009 and is headquartered in San Francisco, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest STEM
- Stem Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Leadership Update, Financial Statements and Exhibits
- SEC Form S-3 filed by Stem Inc.
- SEC Form SD filed by Stem Inc.
- Stem Brings PowerTrack EMS to Latin America's Utility-Scale Hybrid Market with Granja Solar Project in Chile
- Bluesphere Ventures Selects Stem for New York VDER Storage Advisory
- Stem Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Stem Announces First Quarter 2026 Results
- Stem and Nuvation Energy Enter into Agreement to Deliver North American-Made BESS Control Solution
- Stem Acquires raicoon to Expand PowerTrack Capabilities
- SEC Form DEFA14A filed by Stem Inc.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)